One day you thought, Hey, lets do a study where we compare our new fancy drug against our direct competitor currently on the market. If that study shows your competitor has the better drug, well, someone will likely be losing their job
Currently this means: Type 2 diabetes (Ozempic, Mounjaro, Trulicity, Victoza, Rybelsus) Cardiovascular risk reduction in patients with established cardiovascular disease (Ozempic, Victoza) Wegovy and Zepbound, which are FDA-approved only for weight management, are excluded on all Medicare plans
from 500+ happy users Explore the intuitive interface designed to make tracking your GLP-1 medications simple and effective
Not every weight loss journey looks the same
Medicare, Medicaid, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, and TRICARE enrollees are excluded from the card under Lilly's terms
At typical research peptide pricing, this translates to a lower per-dose cost